Insulin resistance and left ventricular hypertrophy in end-stage renal disease: Association between the ENPP1 gene and left ventricular concentric remodelling

Nephrology Dialysis Transplantation

Volumn 27, Issue 2, 2012, Pages 661-666

  Spoto, Belinda ^a   Testa, Alessandra ^a   Parlongo, Rosa M ^a   Tripepi, Giovanni ^a   Trischitta, Vincenzo ^b   Mallamaci, Francesca ^a   Zoccali, Carmine ^a  

^a CNR   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

ENPP1; ESRD; gene polymorphism; insulin resistance; left ventricular hypertrophy

Indexed keywords

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENPP1 GENE; ETHNIC GROUP; FEMALE; GENE; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART LEFT VENTRICLE CONCENTRIC REMODELLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE VOLUME; HUMAN; INSULIN RESISTANCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; ECHOCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART FUNCTION TESTS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHORIC DIESTER HYDROLASES; POLYMORPHISM, GENETIC; PROGNOSIS; PYROPHOSPHATASES; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; VENTRICULAR REMODELING;

EID: 84856896330     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr281     Document Type: Article

References (29)

1. Zoccali C. How important is echocardiography for risk stratification in follow-up of patients with chronic kidney disease? Nat Clin Pract Nephrol 2007; 3: 178-179
2. Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009; 4 (Suppl 1): S79-S91
3. DeFronzo RA, Andres R, Edgar P et al. Carbohydrate metabolism in uremia: a review. Medicine (Baltimore) 1973; 52: 469-481
4. Shinohara K, Shoji T, Emoto M et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with endstage renal disease. J Am Soc Nephrol 2002; 13: 1894-1900
5. Fliser D, Pacini G, Engelleiter R et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53: 1343-1347
6. Alvestrand A, Mujagic M, Wajngot A et al. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance. Clin Nephrol 1989; 31: 175-183
7. Guarnieri G, Zanetti M, Vinci P et al. Insulin resistance in chronic uremia. J Ren Nutr 2009; 19: 20-24
8. Verdecchia P, Reboldi G, Schillaci G et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999; 100: 1802-1807
9. Paolisso G, Galderisi M, Tagliamonte MR et al. Myocardial wall thickness and left ventricular geometry in hypertensives. Relationship with insulin. Am J Hypertens 1997; 10: 1250-1256
10. Perticone F, Maio R, Ruberto C et al. Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension. Am J Kidney Dis 2008; 52: 74-84
11. Kalantar-Zadeh K, Block G, Humphreys MH et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808
12. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32: 1-22
13. Zoccali C, Testa A, Spoto B et al. Mendelian randomization: a new approach to studying epidemiology in ESRD. Am J Kidney Dis 2006; 47: 332-341
14. Goldfine ID, Maddux BA, Youngren JF et al. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev 2008; 29: 62-75
15. Meyre D, Bouatia-Naji N, Tounian A et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet 2005; 37: 863-867
16. Baratta R, Rossetti P, Prudente S et al. Role of the ENPP1 K121Q polymorphism in glucose homeostasis. Diabetes 2008; 57: 3360-3364
17. Stolerman ES, Manning AK, McAteer JB et al. Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes 2008; 57: 1971-1977
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
19. Zoccali C, Benedetto FA, Mallamaci F et al. Inflammation associated with carotid atherosclerosis in dialysis patients. J Hypertens 2000; 18: 1207-1213
20. Peixoto AJ, Santos SF, Mendes RB. Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis 2000; 36: 983-990
21. Zoccali C, Benedetto FA, Mallamaci F et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12: 2768-2774
22. Foley RN, Parfrey PS, Harnett JD et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-2031
23. Ganau A, Saba PS, Roman MJ et al. Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens 1995; 13: 1818-1822
24. Altman DG. Practical Statistics for Medical Research. 1st edn. London: Chapman and Hall, 1991
25. Levy D, Garrison RJ, Savage DD et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566
26. Samuelsson AM, Bollano E, Mobini R et al. Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways. Am J Physiol Heart Circ Physiol 2006; 291: H787-H796
27. Anan F, Takahashi N, Ooie T et al. Candesartan, an angiotensin II receptor blocker, improves left ventricular hypertrophy and insulin resistance. Metabolism 2004; 53: 777-781
28. Zolty R, Hynes PJ, Vittorio TJ. Severe left ventricular systolic dysfunction may reverse with renal transplantation: uremic cardiomyopathy and cardiorenal syndrome. Am J Transplant 2008; 8: 2219-2224
29. Perticone F, Maio R, Di Paola R et al. Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation. Nutr Metab Cardiovasc Dis 2007; 17: 181-187